An evaluation of adverse events following an immunization campaign with the live, attenuated SA14-14-2 Japanese encephalitis vaccine in Cambodia

INTRODUCTION: Japanese encephalitis (JE) virus is the most common cause of vaccine-preventable encephalitis in Asia. The SA14-14-2 JE vaccine manufactured by Chengdu Institute of Biological Products has been shown to be safe and effective in clinical trials and childhood routine immunization program...

Descripción completa

Detalles Bibliográficos
Autores principales: Hills, Susan L., Soeung, Sann Chan, Sarath, Svay, Morn, Chheng, Dara, Cheam, Fischer, Marc, Thigpen, Michael C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9182652/
https://www.ncbi.nlm.nih.gov/pubmed/35679297
http://dx.doi.org/10.1371/journal.pone.0269480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9182652/
https://www.ncbi.nlm.nih.gov/pubmed/35679297
http://dx.doi.org/10.1371/journal.pone.0269480

Ejemplares similares